Inventor · disambiguated record
William Poueymirou
Also filed as: POUEYMIROU WILLIAM
11 granted patents·2 pending applications·987 citations·filing 2005–2017
93Inventor score
Top patents by PatentIndex Score
13 records- 0198US7659442B2Method for making homozygous genetic modificationsREGENERON PHARMA·Filed 2007·Granted Feb 9, 2010·239 cites·18 claims
- 0298US7576259B2Method for making genetic modificationsREGENERON PHARMA·Filed 2007·Granted Aug 18, 2009·236 cites·18 claims
- 0398US7294754B2Method for generating an animal homozygous for a genetic modificationREGENERON PHARMA·Filed 2005·Granted Nov 13, 2007·445 cites·15 claims
- 0497US9730434B2Methods and compositions for generating a mouseREGENERON PHARMA·Filed 2016·Granted Aug 15, 2017·11 cites·27 claims
- 0596US10039269B2Methods and compositions for generating a mouseREGENERON PHARMA·Filed 2017·Granted Aug 7, 2018·10 cites·21 claims
- 0695US9414575B2Methods and compositions for generating a mouseREGENERON PHARMA·Filed 2014·Granted Aug 16, 2016·12 cites·25 claims
- 0791US8816150B2Conditioned culture mediaPOUEYMIROU WILLIAM·Filed 2007·Granted Aug 26, 2014·14 cites·19 claims
- 0889US9655351B2Production of fertile XY female animals from XY ES cellsREGENERON PHARMA·Filed 2016·Granted May 23, 2017·3 cites·42 claims
- 0989US9398762B2Production of fertile XY female animals from XY ES cellsREGENERON PHARMA·Filed 2014·Granted Jul 26, 2016·7 cites·21 claims
- 1088US9149026B2Production of fertile XY animals from XY ES cellsAUERBACH WOJTEK·Filed 2011·Granted Oct 6, 2015·8 cites·9 claims
- 1187US9885058B2Production of fertile XY female mice from XY mouse ES cellsREGENERON PHARMA·Filed 2017·Granted Feb 6, 2018·2 cites·26 claims
- 1262US2009271884A1ES Cell-Derived Mice From Diploid Host Embryo InjectionREGENERON PHARMA·Filed 2009·Application pending·0 cites
- 1351US2016316728A1ES Cell-Derived Mice From Diploid Host Embryo InjectionREGENERON PHARMA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Poueymirou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →